Eray Gökkurt
Eray Gökkurt publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Hematology, on topics such as Gastric Cancer Management and Outcomes, Multiple Myeloma Research and Treatments and Colorectal Cancer Treatments and Studies.
- World rank
- #2,953,794 of 7,710,434 ranked researchers
- Rank in Germany
- #146,835 of 364,343
- Works
- 21
- Citations
- 402
- Citations per work
- 19.1
What does Eray Gökkurt research?
Eray Gökkurt's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (5%), Economics, Econometrics and Finance (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1467.8%
- Medicine1467.8%
- Everything else523.7%
- Life Sciences15.1%
- Social Sciences13.4%
- 1Oncology25% of their works
- 2Pulmonary and Respiratory Medicine20% of their works
- 3Hematology12% of their works
- 4Surgery10% of their works
- 5Molecular Biology5% of their works
- 6Economics and Econometrics3% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Multiple Myeloma Research and Treatments
- Colorectal Cancer Treatments and Studies
- Esophageal Cancer Research and Treatment
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Myeloid Leukemia Research
Which keywords describe Eray Gökkurt's research?
The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Gastric Cancer, Molecular Characterization, Cetuximab, Diagnosis Criteria, Esophageal Carcinoma and International Myeloma Working Group.
- Myelofibrosis
- Acute Myeloid Leukemia
- Targeted Therapy
- Immune Checkpoint Blockade
- Preoperative Chemoradiotherapy
- International Myeloma Working Group
- Diagnosis Criteria
- Molecular Characterization
- Endoscopic Resection
- Chemotherapy
- Gastric Cancer
- Cetuximab
- Esophageal Carcinoma
- KRAS Mutations
- EGFR Mutations
- PD-1 and PD-L1
- AML
- JAK2 Mutation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Chemotherapy102 topics
- Endoscopic Resection102 topics
- Gastric Cancer61 topic
- Molecular Characterization61 topic
- Cetuximab41 topic
- Diagnosis Criteria41 topic
- Esophageal Carcinoma41 topic
- International Myeloma Working Group41 topic
- KRAS Mutations41 topic
- Preoperative Chemoradiotherapy41 topic
- EGFR Mutations31 topic
- Immune Checkpoint Blockade31 topic
- PD-1 and PD-L131 topic
- Targeted Therapy31 topic
- AML21 topic
- Acute Myeloid Leukemia21 topic
- JAK2 Mutation21 topic
- Myelofibrosis21 topic
Where does Eray Gökkurt work?
Eray Gökkurt's main affiliation in the publication record is Eppendorf (Germany), Germany.
How many publications and citations does Eray Gökkurt have?
OpenAlex counts 21 works and 402 citations for Eray Gökkurt, an h-index of 6, ranking #2,953,794 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Eray Gökkurt. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.